Current Oncology Reports

Article	Citations
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?	141
New Developments in VHL-Associated Neuroendocrine Neoplasms	132
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	123
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges	83
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer	81
Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need	74
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients	73
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success	69
Richter’s Transformation	69
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	65
Asparaginase: How to Better Manage Toxicities in Adults	61
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach	51
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?	48
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	47
Oncolytic Viruses and Cancer Immunotherapy	41
Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?	39
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer	39
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?	37
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?	35
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach	33
Cardiotoxicity of Immune Checkpoint Inhibitors	33
Germline Mutations and Ancestry in Prostate Cancer	32
First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly	32
New Insights on Tramadol and Immunomodulation	31
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	31

Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions	30
NRG1 Fusions: The New Kid on the Block	30
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies	30
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	29
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	28
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	27
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan	27
Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant	26
Management of Upper Tract Urothelial Carcinoma	26
Robotic Surgery for Head and Neck Tumors: What are the Current Applications?	26
Surgical Management of Melanoma: Advances and Updates	26
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic	25
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review	25
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology	25
Newly Diagnosed Glioblastoma in Elderly Patients	23
Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications	23
Return to Intended Oncological Therapy: State of the Art and Perspectives	23
Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer	23
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	22
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse	22
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?	22
Diagnostic and Therapeutic Updates in Leptomeningeal Disease	22
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	22
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	22
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	22
The Microbiome’s Influence on Head and Neck Cancers	22
Kidney Cancer Integrative Oncology: Possible Options for Care	22
Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions	22
New Treatments for Recurrent Uterine Cancer	21
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	20
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy	20
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	20
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment	19
Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease	19
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	19
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	19
Immune Checkpoint Inhibitors in the Aged	19
Quality of Life and Survivorship in Lymphoma	18
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge	18
Current Management of Refractory Germ Cell Tumors	18
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	18
Cardiovascular Toxicities of CAR T-cell Therapy	17
How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?	17
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity	17
Current Understanding and Management of Intraductal Carcinoma of the Prostate	17
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	17
The Care of the Leukemic Patients in Times of SARS-CoV-2	17
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	17
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	16
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts	16

Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review	16
Incorporation of Palliative Care in Gynecologic Oncology	16
Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic	16
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis	16
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	16
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	15
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	15
WEE1 Inhibitor: Clinical Development	15
Prostate Cancer Immunotherapy—Finally in From the Cold?	15
CAR T-Cell Therapy in the Older Person: Indications and Risks	15
Interventions to Reduce Sedentary Behavior in Cancer Patients and Survivors: a Systematic Review	15
Fatty Acid Metabolism and Cancer Immunotherapy	15
Treatment of Metastatic Melanoma in the Elderly	15
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	15
Brain Prehabilitation for Oncologic Surgery	14
Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges	14
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice	14
Approach to the Older Patient with Acute Myeloid Leukemia	14
Hairy Cell Leukemia: Where Are We in 2023?	14
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer	14
Metronomic Chemotherapy in Elderly Patients	14
The Emerging Role of Next-Generation Imaging in Prostate Cancer	14
Immunotherapy in Biliary Tract Cancers: Where Are We?	14
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors	14
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022	13
Interventional Treatment Options for Post-mastectomy Pain	13
Neutropenia and Infection Prophylaxis in Childhood Cancer	13
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies	13
Radiation and Melanoma: Where Are We Now?	13
CDK4/6 inhibitors: The Devil is in the Detail	13
Bystander effect of antibody–drug conjugates: fact or fiction?	13
Management of In-Transit Metastases	13
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable	13
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival	13
Head and Neck Mucosal Melanoma: Where Are We Now?	13
DNA Repair Mechanisms and Therapeutic Targets in Glioma	12
Current Trends and Challenges of Microbiome Research in Prostate Cancer	12
Palliative Care in Pediatric Oncology and Hematopoietic Stem Cell Transplantation	12
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	12
Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer	12
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL	12
Melanoma in Pediatric and Young Adult Patients	12
Engineered T Cells: CAR T Cell Therapy and Beyond	12
Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma	12
Prolymphocytic Leukaemia: an Update on Biology and Treatment	12
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors	12
Interventional Strategies in Cancer-induced Cardiovascular Disease	12
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	12
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine	11
Correction to: Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions	11
Correction: Newly Diagnosed Glioblastoma in Elderly Patients	11
Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence	11
The Difficult Airway in Patients with Cancer	11
Correction to: The Changing Landscape of Lymphoma Associated with HIV Infection	11
Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies	11
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	11
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity	11
Novel Clinical Trials and Approaches in the Management of Glioblastoma	11
Telemedicine and Virtual Interventions in Cancer Rehabilitation: Practical Application, Complications and Future Potentials	11
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	11
Cardiac Effects of BRAF and MEK Inhibitors: Mechanisms and Clinical Management	10
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	10
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia	10
Update on Minimally Invasive Surgical Approaches for Rectal Cancer	10
Emerging Role of Biomarkers in Testicular Germ Cell Tumors	10
Approaches to Non-Muscle-Invasive Bladder Cancer	10
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	10
Is Myelodysplasia a Consequence of Normal Aging?	10
The Role and Impact of Minimal Residual Disease in NSCLC	10
A Systematic Review and Quality Assessment of Breast Cancer Clinical Practice Guidelines Providing Complementary and Alternative Medicine Recommendations	10
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	10
Organizational Strategies for Providing Cancer Palliative Care to Many	9
Viral and Clinical Oncology of Head and Neck Cancers	9
Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist’s Perspective	9
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours	9
Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients	9
Anti-PD-1: When to Stop Treatment	9
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	9
Perioperative Anticoagulation in Patients with Cancer	9

25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions	9
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	9
Interventional Management of Portal Hypertension in Cancer Patients	9
Diagnosis and Management of Stroke in Adults with Primary Brain Tumor	9
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	8
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data	8
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease	8
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	8
Emerging Therapies for Transthyretin Amyloidosis	8
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?	8
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future	8
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	8
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?	8
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum	8
AXL Inhibitors: Status of Clinical Development	8
Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions	8
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer	8
Racial Disparities in Breast Cancer: from Detection to Treatment	8
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths	8
Cellular Therapy in NSCLC: Between Myth and Reality	8
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	8
Geographical Disparities in Lung Cancer in Canada: A Review	7
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma	7
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy	7
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma	7
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	7
The Impact of Diet and Nutrition on Prostate Cancer – Food for Thought?	7
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors	7
An Overview of Angiogenesis in Bladder Cancer	7
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	7
Art Therapy in Advanced Cancer. A Mapping Review of the Evidence	7
The Microbiome in Advanced Melanoma: Where Are We Now?	7
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	7
Clinicopathological Review of Micropapillary Urothelial Carcinoma	7
Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer	7
Lymphatic Interventions in the Cancer Patient	7
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors	7
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	7
Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates	7
Update on Management of Squamous Cell Esophageal Cancer	7
Integrative Approaches in the Treatment of Patients Affected by Lymphoma	7
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	7
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	7
COVID and Lung Cancer	7
Disease Assessments in Patients with Glioblastoma	7
Targeted Therapy for Melanomas Without BRAF V600 Mutation	7
Update on Percutaneous Ablation for Sarcoma	7
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder	7
Approach to Oligometastatic Cancer in the Elderly Patient	7
Global Perceptions of Women on Breast Cancer and Barriers to Screening	7
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	7
Targeting the mu-Opioid Receptor for Cancer Treatment	7
Artificial Intelligence and Cancer Control: Toward Prioritizing Justice, Equity, Diversity, and Inclusion (JEDI) in Emerging Decision Support Technologies	6
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours	6
Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)	6
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	6
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies	6
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors	6
Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy	6
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	6
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients	6
Neoadjuvant Therapy in Melanoma: Where Are We Now?	6
Navigating the Cancer Screening Decision for Patients with Dementia	6
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges	6
Update on Histological Reporting Changes in Neuroendocrine Neoplasms	6
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside	6
Tele-neuro-oncology: Current Practices and Future Directions	6
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	6
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	6
For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy	6
Immunotherapy in Cervical Cancer	6
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities	6
Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs	6
Chemokine Receptor Antagonists: Role in Oncology	6
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy	6
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?	6
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines	6
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma	5
The Dairy and Cancer Controversy: Milking the Evidence	5
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	5
Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review	5
Patient Navigation in Cancer Treatment: A Systematic Review	5
Recent Progress in Mind–Body Therapies in Cancer Care	5
Appendiceal Neuroendocrine Neoplasms: an Update for 2023	5
The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation	5
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer	5
Perioperative Neurocognitive Function in Glioma Surgery	5
Integrative Approaches to Minimize Peri-operative Symptoms	5
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors	5
CAR T-cell Therapy for Central Nervous System Lymphoma	5
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer	5
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	5
Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors	5
Young People with Cancer: A Growing Population in Need of United Attention	5
Economics of Antibody Drug Conjugates (ADCs): Innovation, Investment and Market Dynamics	5